Tijana Stanković

Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma

Zorica Milošević, Milica Pešić, Tijana Stanković et al. · Translational research · 2014 · 56 citations

Medicine, Molecular Biology, Oncology +14

Identification of Novel Genetic Alterations in Samples of Malignant Glioma Patients

Vedrana Milinković, Jasna Banković, Miodrag Rakić et al. · PLoS ONE · 2013 · 49 citations · Full text

Medicine, Genetics, Molecular Genetics +13

Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma

Miodrag Dragoj, Zorica Milošević, Jasna Banković et al. · Cellular Oncology · 2016 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +14

A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor

Anna Lucia Fallacara, Claudio Zamperini, Ana Podolski-Renić et al. · Cancers · 2019 · 43 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Cytotoxic Activity of Royleanone Diterpenes from <i>Plectranthus madagascariensis</i> Benth

Diogo Matias, Marisa Nicolai, Lucı́lia Saraiva et al. · ACS Omega · 2019 · 40 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13